Pharma 4.0 Continuous mRNA Drug Products Manufacturing

• Main Authors: Andreas Ouranidis (Author), Christina Davidopoulou (Author), Reald-Konstantinos Tashi (Author), Kyriakos Kachrimanis (Author)
• Format: Book
• Published: MDPI AG, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Continuous mRNA drugs manufacturing is perceived to nurture flow processes featuring quality by design, controlled automation, real time validation, robustness, and reproducibility, pertaining to regulatory harmonization. However, the actual adaptation of the latter remains elusive, hence batch-to-c...